ハギワラ　ノブヒサ   Nobuhisa Hagiwara   萩原　誠久    所属   その他 その他    職種   非常勤嘱託
言語種別	英語
発表タイトル	Maintenance Antithrombotic Therapy and Long-term Prognosis in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention -1 year Landmark Analysis-
会議名	The 79th Annual Scientific Meeting of the Japanese Circulation Society
主催者	Japanese Circulation Society
学会区分	全国規模の学会
発表形式	口頭
講演区分	一般
発表者・共同発表者	◎TANIGAITO Yusuke, OOTSUKI Hisao, WATANABE Masahiro, KAMISHIMA Kazuho, NAKAO Masashi, OKAYAMA Dai, HARUKI Shintaro, JUJO Kentaro, ARASHI Hiroyuki, MINAMI Yuichiro, TAKAGI Atsushi, OOTA Yoshimi, TANAKA Hiroyuki, MORI Fumiaki, FUJII Shinya, HONDA Atsushi, YAMAGUCHI Junichi, HAGIWARA Nobuhisa
発表年月日	2015/04/26
開催地 （都市, 国名）	Osaka, JAPAN
学会抄録	PROGRAM JCS 2015 736
概要	The aim of this study was to assess the relationship between maintenance antithrombotic therapy after 1-year and clinical outcomes.Methods and Results: Consecutive 450 patients with atrial fibrillation undergoing percutaneous coronary intervention were enrolled at 8 medical centers. We examined 274 patients who had no adverse event during 1st year and could be followed more than 1-year (landmark point). At 1-year, triple therapy (TT; warfarin + dual anti-platelet therapy) was continued in 123 patients (45%), only 2 patients were on warfarin only. The incidence of major adverse cerebro-cardiovascular events (MACCE; cardiac death, non-fatal myocardial infarction, stroke) and bleeding complications were evaluated in four medical regimens. The results were shown below.Conclusion: Patients who continued TT over 1-year had similar incidence of MACCE but more bleeding complications, compared to other regimens.